Abstract

Platelets are known to contribute to the development of coronary artery atherosclerotic disease by several mechanisms [1]. Platelets are also primarily involved in forming the occlusive thrombus in the narrowed coronary artery that leads to fatal or non-fatal myocardial infarction (heart attack) [1]. It is known that patients with diabetes, hypertension, elevated LDL cholesterol, or patients who smoke have hyperactive platelets [2]. This is likely to exacerbate the atherothrombotic process. A number of clinical trials have shown that aspirin, a platelet inhibitor, given daily significantly reduces the incidence of symptoms of coronary artery disease and heart attacks [3]. It seems reasonable to assume that by taking “something” on a daily basis that turns down platelet activity, one could reduce the contribution of platelets to the development and sequelae of coronary artery disease.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call